Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Sales (2018 - 2025)

Catalyst Pharmaceuticals (CPRX) has disclosed Return on Sales for 11 consecutive years, with 0.35% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 5.0% year-over-year to 0.35%, compared with a TTM value of 0.36% through Dec 2025, up 3.0%, and an annual FY2025 reading of 0.36%, up 3.0% over the prior year.
  • Return on Sales was 0.35% for Q4 2025 at Catalyst Pharmaceuticals, down from 0.36% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.71% in Q4 2022 and bottomed at 0.3% in Q3 2023.
  • Average Return on Sales over 5 years is 0.31%, with a median of 0.34% recorded in 2024.
  • The sharpest move saw Return on Sales tumbled -119bps in 2021, then surged 64bps in 2024.
  • Year by year, Return on Sales stood at 0.24% in 2021, then surged by 193bps to 0.71% in 2022, then tumbled by -78bps to 0.15% in 2023, then skyrocketed by 156bps to 0.39% in 2024, then decreased by -12bps to 0.35% in 2025.
  • Business Quant data shows Return on Sales for CPRX at 0.35% in Q4 2025, 0.36% in Q3 2025, and 0.36% in Q2 2025.